Quantcast
Environmental News for a Healthier Planet and Life

Report: Monsanto May Leave India After Losing GMO Cotton Patent

GMO
Cotton crop in Barnala, India. Ashwani Verma / Flickr

Could Monsanto's six-decade presence in India be coming to a halt?

On Wednesday, the Delhi High Court ruled that the biotech giant cannot claim patents for Bollgard and Bollgard II, its genetically modified cotton seeds, in the country.


Citing India's Patents Act of 1970, the court said that plant varieties and seeds cannot be patented, thereby rejecting Monsanto's attempt to block its Indian licensee, Nuziveedu Seeds Ltd., from selling the seeds.

"What it means is effectively Monsanto has no patent on seeds in India and they have never had it. They have tried to hoodwink the seed companies and farmers for years claiming they have a patent and making huge amounts of money from that," Diya Kapur, a lawyer for Nuziveedu Seeds, told Bloomberg.

As Dilsher Dhillon wrote in Business Insider India, Wednesday's verdict could prompt Monsanto to pull out of the country:

With the latest ruling, Monsanto's claims against Nuziveedu for unpaid royalties have been waived because its patents are invalid. It will now have to settle for the rates decided by the government.

This is a significant blow for Monsanto, the world's largest seed producer, as it currently licenses its seeds to nearly 50 domestic companies through its local joint venture with Mahyco Seeds Ltd. It could, in all probability, lead to the company's complete exit from India.

Monsanto had already threatened to stop business in India after the government imposed price controls on cotton seeds in 2016.

Monsanto first introduced its GM-technology in India in 1995. Today, more than 90 percent of the country's cotton crop is genetically modified. These crops have been inserted with a pest-resistant toxin called Bacillus thuringiensis, or Bt.

Business Insider's Dhillon noted that the ruling has significant implications for Monsanto and farmers alike:

While yields have increased significantly, Monsanto has long been accused of overcharging farmers for its seeds, especially given the fact that their ability to resist pests diminishes with time. The high cost of seeds and royalties left thousands of farmers in a vicious cycle of debt, which inevitably led to many suicides when crops failed. As a result, the government was forced to start regulating Bt cotton prices in 2006.

Hence, the Delhi High Court's ruling can be seen as a moral reckoning on Monsanto. But it also has wider implications. Yes, it will reduce prices for farmers, given that seed licensing companies pass on the royalty costs to them, but it could prove to be the death knell for innovation in the agriculture sector—something that will hurt farmers in the long run.

However, the company's presence in India may ultimately be decided by its pending mega-merger with Bayer AG.

"Bayer is generally seen as a company with a more collaborative approach towards governments. If Bayer sits down at the negotiating table with the Indian government and works out a solution, then it's possible that the next generation of Bt cotton technology may still see the light of day in India at some point in the future, although it may take years," Abhijit R. Akella, vice president at IIFL Institutional Equities, told Mint.

A Monsanto India spokesman said the company was "very disappointed" with the court's ruling.

"Today's order will have wide-ranging, negative implications for biotech-based innovation across many sectors within India, and is inconsistent with other international markets where agricultural innovation has flourished," the spokesman said.

Monsanto said it might challenge the decision in India's Supreme Court.

EcoWatch Daily Newsletter

The Ernest N. Morial Convention Center in New Orleans, Louisiana has been converted to a 1,000-bed field hospital for coronavirus patients to alleviate stress on local hospitals. Chris Graythen / Getty Images

An area in Louisiana whose predominantly black and brown residents are hard-hit by health problems from industry overdevelopment is experiencing one of the highest death rates from coronavirus of any county in the United States.

Read More Show Less
A woman lies in bed with the flu. marka/Universal Images Group via Getty Images

A central player in the fight against the novel coronavirus is our immune system. It protects us against the invader and can even be helpful for its therapy. But sometimes it can turn against us.

Read More Show Less
Sponsored
Several flower species, including the orchid, can recover quickly from severe injury, scientists have found. cunfek / iStock / Getty Images Plus

Calling someone a delicate flower may not sting like it used to, according to new research. Scientists have found that many delicate flowers are actually remarkably hearty and able to bounce back from severe injury.

Read More Show Less
A Boeing 727 flies over approach lights with a trail of black-smoke from the engines on April 9, 2018. aviation-images.com / Universal Images Group via Getty Images

With global air travel at a near standstill, the airline industry is looking to rewrite the rules it agreed to tackle global emissions. The Guardian reports that the airline is billing it as a matter of survival, while environmental activists are accusing the industry of trying to dodge their obligations.

Read More Show Less
A National Guard member works on election day at a polling location on April 7, 2020 in Madison, Wisconsin. Andy Manis / Getty Images.

ByJulia Baumel

The outbreak of COVID-19 across the U.S. has touched every facet of our society, and our democracy has been no exception.

Read More Show Less